Insights

Commercialization Focus Aditxt is actively shifting toward commercialization and revenue execution, evidenced by leadership changes and strategic moves such as appointing an interim CEO to drive market-ready opportunities in precision oncology diagnostics.

Strategic Acquisitions The acquisition of Ignite Proteomics positions Aditxt to broaden its oncology portfolio and offers a growth avenue through an integrated precision oncology platform, creating cross-sell opportunities for diagnostics, testing services, and related health innovations.

Spinout Momentum The planned spinout of Ignite Proteomics via a sizable public market transaction signals a focus on unlocking value from portfolio assets and may open partnership, licensing, or collaboration avenues with investors and biopharma players seeking specialized cancer diagnostic capabilities.

Leadership Signals New interim CEO with healthcare and public-company background suggests a push toward revenue generation, clinical validation, and scaled sales efforts, making the company more attractive for enterprise customers and strategic partners in health tech.

Platform Synergies As a social innovation platform with a broad health-improvement mission, there are opportunities to partner with pharmaceutical, diagnostic, and healthcare organizations seeking innovative solutions, potential co-development programs, and pilot collaborations leveraging Aditxt’s tech stack and network.

Similar companies to aditXt (Nasdaq: ADTX)

aditXt (Nasdaq: ADTX) Tech Stack

aditXt (Nasdaq: ADTX) uses 8 technology products and services including Facebook Pixel, WordPress, Zoho, and more. Explore aditXt (Nasdaq: ADTX)'s tech stack below.

  • Facebook Pixel
    Analytics
  • Content Management System
  • Customer Relationship Management
  • oEmbed
    Dev Tools
  • Generative Ai
  • jQuery
    Javascript Libraries
  • Facebook Share Button
    Miscellaneous

Media & News

aditXt (Nasdaq: ADTX)'s Email Address Formats

aditXt (Nasdaq: ADTX) uses at least 1 email format:
aditXt (Nasdaq: ADTX) Email FormatsExamplePercentage
FLast@aditxt.comJDoe@aditxt.com
100%

Frequently Asked Questions

What is aditXt (Nasdaq: ADTX)'s stock symbol?

Minus sign iconPlus sign icon
aditXt (Nasdaq: ADTX) is a publicly traded company; the company's stock symbol is ADTX.

What is aditXt (Nasdaq: ADTX)'s official website and social media links?

Minus sign iconPlus sign icon
aditXt (Nasdaq: ADTX)'s official website is aditxt.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does aditXt (Nasdaq: ADTX) generate?

Minus sign iconPlus sign icon
As of August 2026, aditXt (Nasdaq: ADTX)'s annual revenue is estimated to be <$1M.

What is aditXt (Nasdaq: ADTX)'s NAICS code?

Minus sign iconPlus sign icon
aditXt (Nasdaq: ADTX)'s NAICS code is 923 - Administration of Human Resource Programs.

How many employees does aditXt (Nasdaq: ADTX) have currently?

Minus sign iconPlus sign icon
As of August 2026, aditXt (Nasdaq: ADTX) has approximately 11 employees across 1 continents, including North America. Key team members include Vice President Of Strategic Accounts - Aditxtscore Division: S. D., Head Of Aditxtscore Division At Aditx Therapeutics, Inc. (nasdaq Adtx): A. E. and Co-Founder, Chairman And Ceo: A. A. Explore aditXt (Nasdaq: ADTX)'s employee directory with LeadIQ.

What industry does aditXt (Nasdaq: ADTX) belong to?

Minus sign iconPlus sign icon
aditXt (Nasdaq: ADTX) operates in the Health and Human Services industry.

What technology does aditXt (Nasdaq: ADTX) use?

Minus sign iconPlus sign icon
aditXt (Nasdaq: ADTX)'s tech stack includes Facebook Pixel, WordPress, Zoho, oEmbed, Microsoft 365, OpenAI, jQuery and Facebook Share Button.

What is aditXt (Nasdaq: ADTX)'s email format?

Minus sign iconPlus sign icon
aditXt (Nasdaq: ADTX)'s email format typically follows the pattern of FLast@aditxt.com. Find more aditXt (Nasdaq: ADTX) email formats with LeadIQ.

How much funding has aditXt (Nasdaq: ADTX) raised to date?

Minus sign iconPlus sign icon
As of August 2026, aditXt (Nasdaq: ADTX) has raised $80M in funding. The last funding round occurred on Aug 09, 2024 for $1.2M.

When was aditXt (Nasdaq: ADTX) founded?

Minus sign iconPlus sign icon
aditXt (Nasdaq: ADTX) was founded in 2017.
aditXt (Nasdaq: ADTX) logo

aditXt (Nasdaq: ADTX)

Health and Human ServicesVirginia, United States11-50 Employees

Aditxt is a health and human services company based in Richmond, Virginia, operating as a social innovation platform focused on accelerating health innovations with broad societal impact. The organization describes itself as Nasdaq-listed and aims to mobilize a global community of stakeholders to discover, develop, and deploy health solutions that could benefit humanity, emphasizing collaboration and social capital in advancing promising technologies. Its recent activity includes strategic corporate moves such as the acquisition of Ignite Proteomics and leadership changes intended to shift toward commercialization and revenue execution in its precision oncology diagnostics efforts. With a relatively small to mid-sized footprint, the company positions itself within the health innovations space, seeking to address diverse health challenges—from autoimmune and infectious diseases to cancer and reproductive health—by translating untapped ideas into implementable solutions. The company indicates a focus on creating a platform where innovations can be discovered and applied to real-world healthcare needs, leveraging a network of stakeholders to enable deployment of new health solutions.

Section iconCompany Overview

Website
aditxt.com
Stock Symbol
ADTX
NAICS Code
923 - Administration of Human Resource Programs
Founded
2017
Employees
11-50

Section iconFunding & Financials

  • $80M

    aditXt (Nasdaq: ADTX) has raised a total of $80M of funding over 9 rounds. Their latest funding round was raised on Aug 09, 2024 in the amount of $1.2M as a Post IPO Equity.

  • <$1M

    aditXt (Nasdaq: ADTX)'s revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.